Xconomy’s Digital Events →
Roger Perlmutter is Amgen’s executive vice president of R&D.
Sponsored · Video
A Fireside Chat with Biocom President & CEO Joe Panetta
Xconomy Insight · Special Report
Insights, wisdom, and inspiration on what it takes
Sponsored · Whitepaper
Virtual/hybrid trials and decentralized research can better integrate healthcare into patients’ lives and accelerate approval of new medications
© 2007-2021, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.